Ignite Creation Date:
2024-05-05 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00481455
Status:
COMPLETED
Last Update Posted:
2008-11-25
First Post:
2007-05-30
Brief Title:
Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion NCD in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme GBM
Sponsor:
CASI Pharmaceuticals Inc
Organization:
CASI Pharmaceuticals Inc
Organization Data
Organization:
CASI Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
ME-CLN-007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CASI Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Chief Medical Officer
Old Organization:
EntreMed Inc